This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Anges Mg, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Tateki Kubo: Innovator in Tissue Survival Enhancement
Introduction
Tateki Kubo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of tissue survival through his innovative research and inventions. His work focuses on enhancing the survival of organ transplants and skin grafts, which is crucial in medical procedures.
Latest Patents
Kubo holds a patent for a groundbreaking invention titled "Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival." This patent relates to the use of growth factors to improve tissue survival. Specifically, it describes methods for enhancing the survival of organ transplants, musculocutaneous flaps, or skin grafts by administering a nucleic acid sequence encoding hepatocyte growth factor. He has 1 patent to his name.
Career Highlights
Throughout his career, Kubo has been associated with Anges Mg, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing medical technologies that improve patient outcomes in surgical procedures.
Collaborations
Kubo has collaborated with notable colleagues, including Marvin A. Tanag and Kenji Yano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tateki Kubo's contributions to the field of tissue survival enhancement highlight his role as an influential inventor. His innovative patent and collaborations with esteemed colleagues underscore his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile